Related Experiment Video
Updated: May 6, 2026
Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
Published on: August 14, 2017
Improved mortality prediction for pediatric acute liver failure using dynamic prediction strategy
Ruosha Li1, Jingyan Wang1, Cuihong Zhang1
1Department of Biostatistics and Data Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Insights
Developing a dynamic prediction tool for pediatric acute liver failure (PALF) mortality using serial measurements significantly improves risk assessment. This tool aids in timely medical decisions for better patient outcomes.
Area of Science:
- Hepatology
- Pediatric Critical Care
- Biostatistics
Background:
- Pediatric acute liver failure (PALF) has a rapid and heterogeneous clinical course.
- Accurate and updated mortality risk prediction is crucial for managing PALF.
Purpose of the Study:
- To develop and validate a dynamic prediction tool for PALF mortality.
- To capture the dynamic clinical course for improved risk prediction.
Main Methods:
- Utilized data from 1144 PALF participants over 15 years.
- Employed joint modeling to combine longitudinal trajectories of key variables (INR, bilirubin, etc.).
- Assessed predictive performance using area under the curve (AUC) via cross-validation and split-by-time validation.
Main Results:
- A prognostic joint model was constructed using temporal trajectories of five variables.
- Dynamic prediction improved performance over static prediction (AUC increased from 0.784 to 0.887).
- Validation showed consistent performance across different time subsets.
Conclusions:
- Serial measurements in early PALF effectively capture disease dynamics and enhance mortality risk prediction.
- Continuous monitoring and updated prognosis support timely and informed medical decisions.
Objectives:
To develop and validate a prediction tool for pediatric acute liver failure (PALF) mortality risks that captures the rapid and heterogeneous clinical course for accurate and updated prediction.
Methods:
Data included 1144 participants with PALF enrolled during three phases of the PALF registry study over 15 years. Using joint modeling, we built a dynamic prediction tool for mortality by combining longitudinal trajectories of multiple laboratory and clinical variables. The predictive performance for 7-day and 21-day mortality was assessed using the area under curve (AUC) through cross-validation and split-by-time validation.
Results:
We constructed a prognostic joint model that combines the temporal trajectories of international normalized ratio, total bilirubin, hepatic encephalopathy, platelet count, and serum creatinine. Dynamic prediction using updated information improved predictive performance over static prediction using the information at enrollment (Day 0) only. In cross-validation, AUC increased from 0.784 to 0.887 when measurements obtained between Days 1 and 2 were incorporated. AUC remained similar when we used the earlier subset of the sample for training and the later subset for testing.
Conclusions:
Serial measurements of five variables in the first few days of PALF capture the dynamic clinical course of the disease and improve risk prediction for mortality. Continuous disease monitoring and updating risk prognosis are beneficial for timely and judicious medical decisions.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test